Somatic NS + Drug Classifications Flashcards
somatic NS
voluntary
skeletal muscle contraction
neurons connect with skeletal muscle fibers at NMJ
what NT acts on what receptors in somatic NS
ACH on nicotinic 2 receptors
what does somatic NS control
respirations, contraction of diaphragm/chest muscles, tone for mvmt, posture
drug categories and subcategories of somatic NS
- peripheral skeletal muscle relaxants
- depolarizing agents
- non-depolarizing agents
- direct acting agents - centrally acting skeletal muscle relaxants
MOA of skeletal muscle relaxants in general
inhibit skeletal muscle contraction by interfering w neuromuscular function
uses for skeletal muscle relaxants in general
painful injuries
decrease spasms from trauma/overexertion/tension
spastic diseases like cerebral palsy or M.S.
pre-op
MOA of depolarizing agents (peripheral SMR)
binds to Nm receptor and induces depolarization causing muscle fasciculations
alters Nm receptor so it cannot respond to endogenous ACH and prevents contractions from occurring
drugs of depolarizing agents
succinylcholine
side effects of depolarizing agents (succinylcholine)
jaw rigidity, hypotension, arrhythmias
can be toxic if cholinesterase is abnormal
should only be used in emergent situations in ped pts
MOA of non-depolarizing agents (peripheral SMR)
occupies Nm receptor sites, ACH cannot bind, no contraction or depolarization can occur
drugs of non-depolarizing agents
rocuronium bromide (Zemuron®)
antidote for rocuronium bromide (Zemuron®)
neostigmine (Prostigmin®) or sugammadex
uses for non-depolarizing agents (rocuronium bromide (Zemuron®)
intubation, adjunct therapy for anesthesia, mechanical ventilation
side effects for for non-depolarizing agents (rocuronium bromide (Zemuron®)
jaw rigidity, hypotension, arrhythmias, respiratory depression
MOA for direct acting agents (peripheral SMR)
inhibits skeletal muscle contraction, blocks Ca++ release within muscle fiber